| Jeff Andrew Carpenter, CRNA | |
|
1124 W 21st St, Andover, KS 67002-5500 | |
| (316) 300-4000 | |
| Not Available |
| Full Name | Jeff Andrew Carpenter |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 1124 W 21st St, Andover, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164907408 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | TMP-157280 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kansas Medical Center Llc | Andover, KS | Hospital |
| Kansas Spine & Specialty Hospital, Llc | Wichita, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas Anesthesia Providers, Llc | 6305206764 | 22 |
| Kansas Medical Center Llc | 2668476862 | 35 |
| Kansas Spine Anesthesia Corporation Pa | 1153586821 | 44 |
News Archive
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today introduced the next generation of its healthcare management technology with the launch of InFrame™, a collaborative health information exchange (HIE) service that enables care delivery organizations to share clinical data — including diagnostic-quality medical images — among themselves and with patients to more effectively drive business and comply with meaningful use criteria.
Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a new "virtual biopsy" device that can quickly determine a skin lesion's depth and potential malignancy without using a scalpel.
The unexpected behaviour of a family of "superbugs" called the Burkholderia cepacia complex (Bcc) could have implications for the treatment of cystic fibrosis (CF) patients.
SGI-DNA, a Synthetic Genomics, Inc. company, was recently recognized by Frost & Sullivan for its groundbreaking innovation in genomic technologies for the BioXp 3200 System, an instrument with the capacity to simultaneously build 32 unique, double-stranded DNA fragments to study gene function, pathways, and whole genomes.
› Verified 9 days ago
| Entity Name | Wichita Anesthesiology Chartered |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407848450 PECOS PAC ID: 4587577796 Enrollment ID: O20031112000357 |
News Archive
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today introduced the next generation of its healthcare management technology with the launch of InFrame™, a collaborative health information exchange (HIE) service that enables care delivery organizations to share clinical data — including diagnostic-quality medical images — among themselves and with patients to more effectively drive business and comply with meaningful use criteria.
Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a new "virtual biopsy" device that can quickly determine a skin lesion's depth and potential malignancy without using a scalpel.
The unexpected behaviour of a family of "superbugs" called the Burkholderia cepacia complex (Bcc) could have implications for the treatment of cystic fibrosis (CF) patients.
SGI-DNA, a Synthetic Genomics, Inc. company, was recently recognized by Frost & Sullivan for its groundbreaking innovation in genomic technologies for the BioXp 3200 System, an instrument with the capacity to simultaneously build 32 unique, double-stranded DNA fragments to study gene function, pathways, and whole genomes.
› Verified 9 days ago
| Entity Name | Kansas Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255380127 PECOS PAC ID: 2668476862 Enrollment ID: O20061109000659 |
News Archive
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today introduced the next generation of its healthcare management technology with the launch of InFrame™, a collaborative health information exchange (HIE) service that enables care delivery organizations to share clinical data — including diagnostic-quality medical images — among themselves and with patients to more effectively drive business and comply with meaningful use criteria.
Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a new "virtual biopsy" device that can quickly determine a skin lesion's depth and potential malignancy without using a scalpel.
The unexpected behaviour of a family of "superbugs" called the Burkholderia cepacia complex (Bcc) could have implications for the treatment of cystic fibrosis (CF) patients.
SGI-DNA, a Synthetic Genomics, Inc. company, was recently recognized by Frost & Sullivan for its groundbreaking innovation in genomic technologies for the BioXp 3200 System, an instrument with the capacity to simultaneously build 32 unique, double-stranded DNA fragments to study gene function, pathways, and whole genomes.
› Verified 9 days ago
| Entity Name | Kansas Spine Anesthesia Corporation Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720345911 PECOS PAC ID: 1153586821 Enrollment ID: O20120702000174 |
News Archive
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today introduced the next generation of its healthcare management technology with the launch of InFrame™, a collaborative health information exchange (HIE) service that enables care delivery organizations to share clinical data — including diagnostic-quality medical images — among themselves and with patients to more effectively drive business and comply with meaningful use criteria.
Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a new "virtual biopsy" device that can quickly determine a skin lesion's depth and potential malignancy without using a scalpel.
The unexpected behaviour of a family of "superbugs" called the Burkholderia cepacia complex (Bcc) could have implications for the treatment of cystic fibrosis (CF) patients.
SGI-DNA, a Synthetic Genomics, Inc. company, was recently recognized by Frost & Sullivan for its groundbreaking innovation in genomic technologies for the BioXp 3200 System, an instrument with the capacity to simultaneously build 32 unique, double-stranded DNA fragments to study gene function, pathways, and whole genomes.
› Verified 9 days ago
| Entity Name | Kansas Anesthesia Providers, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346977295 PECOS PAC ID: 6305206764 Enrollment ID: O20230717002059 |
News Archive
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today introduced the next generation of its healthcare management technology with the launch of InFrame™, a collaborative health information exchange (HIE) service that enables care delivery organizations to share clinical data — including diagnostic-quality medical images — among themselves and with patients to more effectively drive business and comply with meaningful use criteria.
Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a new "virtual biopsy" device that can quickly determine a skin lesion's depth and potential malignancy without using a scalpel.
The unexpected behaviour of a family of "superbugs" called the Burkholderia cepacia complex (Bcc) could have implications for the treatment of cystic fibrosis (CF) patients.
SGI-DNA, a Synthetic Genomics, Inc. company, was recently recognized by Frost & Sullivan for its groundbreaking innovation in genomic technologies for the BioXp 3200 System, an instrument with the capacity to simultaneously build 32 unique, double-stranded DNA fragments to study gene function, pathways, and whole genomes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeff Andrew Carpenter, CRNA 1124 W 21st St, Andover, KS 67002-5500 Ph: (806) 220-9802 | Jeff Andrew Carpenter, CRNA 1124 W 21st St, Andover, KS 67002-5500 Ph: (316) 300-4000 |
News Archive
A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.
MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today introduced the next generation of its healthcare management technology with the launch of InFrame™, a collaborative health information exchange (HIE) service that enables care delivery organizations to share clinical data — including diagnostic-quality medical images — among themselves and with patients to more effectively drive business and comply with meaningful use criteria.
Using sound vibrations and pulses of near-infrared light, a Rutgers University scientist has developed a new "virtual biopsy" device that can quickly determine a skin lesion's depth and potential malignancy without using a scalpel.
The unexpected behaviour of a family of "superbugs" called the Burkholderia cepacia complex (Bcc) could have implications for the treatment of cystic fibrosis (CF) patients.
SGI-DNA, a Synthetic Genomics, Inc. company, was recently recognized by Frost & Sullivan for its groundbreaking innovation in genomic technologies for the BioXp 3200 System, an instrument with the capacity to simultaneously build 32 unique, double-stranded DNA fragments to study gene function, pathways, and whole genomes.
› Verified 9 days ago
Terry Keith Blue, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1108 E Waterview Dr, Andover, KS 67002 Phone: 316-425-8153 Fax: 316-425-8153 | |
Ms. Sharon L Barocco, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2117 S Andover Rd, Andover, KS 67002 Phone: 316-733-8166 | |
John Phillip Weller, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1124 W 21st St, Andover, KS 67002 Phone: 316-300-4000 | |
Caitlin Carpenter, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1124 W 21st St, Andover, KS 67002 Phone: 316-440-3200 | |
Mrs. Pegah Vahdat Harlan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 945 W Threewood Ct, Andover, KS 67002 Phone: 515-339-6994 | |
Ryan Kaub, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1124 W 21st St, Andover, KS 67002 Phone: 316-300-4000 |